Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03265808
What this trial is testing

Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.

Who this might be right for
Major Depressive DisorderAlcohol Use Disorder
Ihsan M Salloum, MD, MPH 31
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Not applicableStudy completedNCT05819515
What this trial is testing

Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix

Who this might be right for
Gingival Recession
University of Michigan 36
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Early research (Phase 1)UnknownNCT02840123
What this trial is testing

Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Fundació Sant Joan de Déu 10
Early research (Phase 1)Not Yet RecruitingNCT07380659
What this trial is testing

Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock

Who this might be right for
Cardiogenic ShockCardiogenic Shock Post Myocardial InfarctionSTEMI - ST Elevation Myocardial Infarction
Second Affiliated Hospital, Zhejiang University, School of Medicine 18
Testing effectiveness (Phase 2)UnknownNCT03795974
What this trial is testing

Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy

Who this might be right for
Cerebral Palsy, Spastic
Tehran University of Medical Sciences 108
Early research (Phase 1)UnknownNCT02484560
What this trial is testing

Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2

Who this might be right for
Duchenne Muscular Dystrophy
University of Gaziantep 10
Early research (Phase 1)Ended earlyNCT03963024
What this trial is testing

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

Who this might be right for
Irradiated Bone MarrowTransplant-Related Hematologic MalignancyLeukemia, Acute+2 more
IRCCS San Raffaele 9
Testing effectiveness (Phase 2)Ended earlyNCT00784524
What this trial is testing

Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05559827
What this trial is testing

Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Immunological Pure Red Cell Aplasia
Assistance Publique - Hôpitaux de Paris 90
Early research (Phase 1)Study completedNCT01863108
What this trial is testing

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Who this might be right for
MelanomaTumor VaccinesEffects of Immunotherapy
University Hospital, Grenoble 9
Large-scale testing (Phase 3)Study completedNCT00422890
What this trial is testing

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 10
Not applicableUnknownNCT04375579
What this trial is testing

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplant
Assistance Publique - Hôpitaux de Paris 205
Early research (Phase 1)Study completedNCT01462396
What this trial is testing

Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 4
Early research (Phase 1)Temporarily pausedNCT02333162
What this trial is testing

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+1 more
University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT00274846
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 21
Early research (Phase 1)Ended earlyNCT03509870
What this trial is testing

Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds

Who this might be right for
Diabetic Foot Ulcer
Steno Diabetes Center Copenhagen 2
Early research (Phase 1)Looking for participantsNCT07297173
What this trial is testing

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Who this might be right for
Relapsed LeukemiaRefractory Leukemia
Beijing 302 Hospital 5
Early research (Phase 1)WithdrawnNCT04556266
What this trial is testing

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies

Who this might be right for
LeukemiaLymphomaLymphoma, B-Cell
Memorial Sloan Kettering Cancer Center
Next Page